Kodex Biotech
Market Cap
$295.12B
P/E Ratio
—
EPS
—
Dividend Yield
0.12%
52-Week Range
$7260.00 — $14330.00
Volume
997.92K
Avg Volume
2.04M
Beta
0.68
Dividend Yield
—
Annual Dividend
$15.00
Payout Ratio
—
Frequency
—
Ex-Dividend Date
2025-04-29
Cash/Share
—
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
23.76M
Float
0
Free Float %
0.00%
RSI (14)
47.91
SMA 20
$13165.25
SMA 50
$12848.00
SMA 200
$10980.54
ATR (14)
731.07
Volatility (Week)
0.09%
Volatility (Month)
0.05%
Pattern
—
1 Day
+2.68%
1 Week
-4.61%
1 Month
-4.43%
3 Months
+1.54%
6 Months
+35.44%
1 Year
—
YTD
+3.34%
All-Time High
$13855.00
Sector
Financial Services
Industry
Asset Management
Country
KR
Exchange
KSC
IPO Date
2016-05-13
Employees
—
CEO
—
Index Membership
—
Kodex Biotech (244580.KS) is a financial services company in the asset management industry listed on the KSC. With a market capitalization of $295.12B, and a dividend yield of 0.12%, 244580.KS is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 244580.KS against other stocks using dozens of fundamental and technical filters.
No, Kodex Biotech (244580.KS) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Kodex Biotech (244580.KS) has a market capitalization of $295.12 billion, classifying it as a mega-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Kodex Biotech (244580.KS) has returned +3.34% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.